These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15748798)

  • 1. Analyses of neurobehavioral screening data: dose-time-response modeling of continuous outcomes.
    Zhu Y; Wessel MR; Liu T; Moser VC
    Regul Toxicol Pharmacol; 2005 Apr; 41(3):240-55. PubMed ID: 15748798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A probabilistic framework for non-cancer risk assessment.
    Chen JJ; Moon H; Kodell RL
    Regul Toxicol Pharmacol; 2007 Jun; 48(1):45-50. PubMed ID: 17166641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution and current status of neurotoxicity risk assessment.
    Tilson HA
    Drug Metab Rev; 1996; 28(1-2):121-39. PubMed ID: 8744593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From neurotoxic to chemosensory effects: new insights on acute solvent neurotoxicity exemplified by acute effects of 2-ethylhexanol.
    van Thriel C; Kiesswetter E; Schäper M; Blaszkewicz M; Golka K; Juran S; Kleinbeck S; Seeber A
    Neurotoxicology; 2007 Mar; 28(2):347-55. PubMed ID: 16712936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.
    Shipp A; Lawrence G; Gentry R; McDonald T; Bartow H; Bounds J; Macdonald N; Clewell H; Allen B; Van Landingham C
    Crit Rev Toxicol; 2006; 36(6-7):481-608. PubMed ID: 16973444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A practical guide to dose-response analyses and risk assessment in occupational epidemiology.
    Steenland K; Deddens JA
    Epidemiology; 2004 Jan; 15(1):63-70. PubMed ID: 14712148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IPCS Collaborative Study on Neurobehavioral Screening Methods: VI. Agreement and reliability of the data.
    Catalano PJ; McDaniel KL; Moser VC
    Neurotoxicology; 1997; 18(4):1057-64. PubMed ID: 9457734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new model function for continuous data sets in health risk assessment of chemicals using the benchmark dose concept.
    Kalliomaa K; Haag-Grönlund M; Victorin K
    Regul Toxicol Pharmacol; 1998 Apr; 27(2):98-107. PubMed ID: 9671564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of neurobehavioral screening data: benchmark dose estimation.
    Zhu Y; Jia Z; Wang W; Gift JS; Moser VC; Pierre-Louis BJ
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):190-201. PubMed ID: 15869831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IPCS Collaborative Study on Neurobehavioral Screening Methods: III. Results of proficiency studies. Steering Group.
    Moser VC; Becking GC; Cuomo V; Frantík E; Kulig BM; MacPhail RC; Tilson HA; Winneke G; Brightwell WS; Cagiano R; Gill MW; Haggerty GC; Hornychová M; Lammers J; Larsen JJ; McDaniel KL; Nelson BK; Ostergaard G
    Neurotoxicology; 1997; 18(4):939-46. PubMed ID: 9457731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model studies for evaluating the acute neurobehavioral effects of complex hydrocarbon solvents I. Validation of methods with ethanol.
    McKee RH; Lammers JH; Hoogendijk EM; Emmen HH; Muijser H; Barsotti DA; Owen DE; Kulig BM
    Neurotoxicology; 2006 Dec; 27(6):1064-79. PubMed ID: 16831461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing experimental designs for benchmark dose calculations for continuous endpoints.
    Kuljus K; von Rosen D; Sand S; Victorin K
    Risk Anal; 2006 Aug; 26(4):1031-43. PubMed ID: 16948695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative risk assessment for developmental neurotoxic effects.
    Razzaghi M; Kodell R
    Risk Anal; 2004 Dec; 24(6):1673-81. PubMed ID: 15660620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurobehavioral performance of adult and adolescent agricultural workers.
    Rohlman DS; Lasarev M; Anger WK; Scherer J; Stupfel J; McCauley L
    Neurotoxicology; 2007 Mar; 28(2):374-80. PubMed ID: 17141876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simulation study of quantitative risk assessment for bivariate continuous outcomes.
    Yu ZF; Catalano PJ
    Risk Anal; 2008 Oct; 28(5):1415-30. PubMed ID: 18631306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exact analysis of dose response for multiple correlated binary outcomes.
    Han KE; Catalano PJ; Senchaudhuri P; Mehta C
    Biometrics; 2004 Mar; 60(1):216-24. PubMed ID: 15032792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.